Beauty Blend is a vendor-crafted peptide mix combining GHK (or its copper form, GHK-Cu) with KPV, marketed together for skin, hair, and anti-inflammatory benefits rather than sold as a single characterized compound. On dosing, reported amounts span 200 mcg to 2 mg, most commonly landing at 2 mg, though most posters don't state a timing or cycling schedule. The honest caveat: there's no FDA-approved indication for this blend, so every human use is off-label or compounded, and the pairing is a vendor formulation rather than a studied protocol.
Data last updated
Measured on 0 of 6 axes
Evidence shape
Beauty Blend, a combination of GHK and KPV, currently lacks any published human clinical evidence. There are no registered trials, completed studies, or mapped indications for this specific formulation in the scientific literature. Because no data exists to support its use, the efficacy and safety profile of this peptide blend remain entirely unverified in human subjects.
Human evidence
No human study rows have been captured for this peptide yet.
Lower-tier support
No animal or in-vitro support rows have been captured yet.
Published literature
The research corpus was searched; no standalone peptide-level publications were indexed beyond the trials and preclinical rows above.
Source data
Clinical research side effects
Clinical safety table not projected yet.
Anecdotal side effects
Symptom-relevant clinical or community evidence has not been captured for this peptide yet.
No live vendor pricing captured for this peptide yet.
How BEAUTY BLEND (GHK + KPV) is dosed across research, clinician, and community sources — each evidence tier kept separate so the dose range, frequency, timing, and cycling stay visible without flattening different levels of evidence.
No structured protocol details captured for this tier yet.
No structured protocol details captured for this tier yet.
The typical dose reported is 2 mg subcutaneously, with a range from 200 µg up to 2 mg; no frequency or cycling pattern was specified in the community reports.